8C86
Crystal structure of human transthyretin in complex with 3-O-methyltolcapone analogue 2
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PETRA III, EMBL c/o DESY BEAMLINE P13 (MX1) |
Synchrotron site | PETRA III, EMBL c/o DESY |
Beamline | P13 (MX1) |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2021-12-03 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.885 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 41.961, 84.875, 63.020 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 42.440 - 1.100 |
R-factor | 0.1391 |
Rwork | 0.138 |
R-free | 0.15760 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.015 |
RMSD bond angle | 1.347 |
Data reduction software | XDS |
Data scaling software | Aimless |
Refinement software | PHENIX (1.19.2_4158) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 42.440 | 1.120 |
High resolution limit [Å] | 1.100 | 1.100 |
Rmerge | 0.082 | 1.091 |
Rpim | 0.034 | 0.467 |
Number of reflections | 657887 | 4420 |
<I/σ(I)> | 9.4 | 1.6 |
Completeness [%] | 99.7 | |
Redundancy | 7.2 | |
CC(1/2) | 0.995 | 0.654 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 298 | 0.2 M calcium acetate hydrate, 0.1 M Tris 7.5, and 25% w/v PEG 2000 MME |